Targeting CLL-1 for acute myeloid leukemia therapy

Overview of attention for article published in Journal of Hematology & Oncology, April 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog
twitter: 3 X users

patent: 5 patents
reddit: 1 Redditor

Citations

dimensions_citation: 60 Dimensions

Readers on

mendeley: 98 Mendeley

Summary News Blogs X Patents Reddit Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

CLL1：急性髓性白血病靶点研究进展

CN-Healthcare, 08 Mar 2023

急性髓性白血病（AML）是成人患者中最常见和最致命的血液恶性肿瘤，大多数患者的预后很差。尽管现阶段免疫疗法在血液瘤和实体瘤领域发挥了重要作用，但由于缺乏高特异性的目标抗原和AML的异质性，免疫疗法在AML上的进展非常缓慢，AML目前的治疗手段仍以化疗和造血干…

Targeting CLL-1 for acute myeloid leukemia therapy

Medical Health News, 25 Apr 2019

C-type lectin-like receptors play a pivotal role in the fight against infection and maintain homeostasis and self-tolerance by…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.